Public procurement notice: Contract Notice
Published: 2017-05-24
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Country: UK
Region: SCOTLAND
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products
Estimated value: 20510000 GBP
Submission deadline: 2017-06-26
Award criteria: The most economic tender

Technical requirements: Supply of Tenofovir Disoproxil Tablets and Granules, Emtricitabine/Tenofovir Disoproxil Tablets and Entecavir Tablets and Oral Solution to NHS Scotland.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
This Lot is for the supply of tenofovir disoproxil tablets and granules to NHS Scotland. This will require supply of the medicines direct to hospitals and nominated home delivery supplier(s) as directed by the Authority.
Each product line will be treated as an individual Lot and awarded on a line by line basis to a single supplier.
There is the option to extend the framework agreement by two (2) further periods of up to twelve (12) months each upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
This framework agreement is for the supply of Tenofovir Disoproxil/Emtricitabine tablets to NHS Scotland. This will require supply of the medicines direct to hospitals and nominated home delivery supplier(s) as directed by the Authority.
This Lot will be awarded as a ranked multi supplier framework to an envisaged maximum of five (5) suppliers.
There is the option to extend the framework agreement by two (2) further periods of up to twelve (12) months each upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
This framework agreement is for the supply of Entecavir tablets and oral solution to NHS Scotland. This will require supply of medicines direct to hospitals and nominated home delivery supplier(s) as directed by the Authority.
Each product line will be treated as an individual Lot and awarded on a line by line basis to a single supplier.
There is the option to extend the framework agreement by two (2) further periods of up to twelve (12) months each upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.
Economic operators may be excluded from this competition if they are in breach of any of the situations referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines prior to the commencement of the Framework Agreement.

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any of the situations referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 20510000